In 2013, the Company completed dosage formulations facility at SEZ Pithampur and made agreement to sell the same to Mylan Laboratories Limited. During the year 2015, Synchron Research Private ...

In a report released today, Thomas O’Malley from Barclays maintained a Hold rating on Silicon Laboratories (SLAB – Research Report), with a price target of $120.00. The company’s shares ...

Pfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane. The five-year deal aims to enhance distribution and ...

Divis Laboratories Limited is among India’s leading pharmaceutical companies. The firm is headquartered in Hyderabad, Andhra Pradesh. Divis Laboratories is primarily known for the production of ...

Morepen Laboratories Ltd share price was down by -0.55% from the previous closing price of ₹45.08. Who are peers of Morepen Laboratories Ltd? The peers of Morepen Laboratories Ltd are Sun ...

Neon is partnering with independent bookstores in New York City and Los Angeles to give away free limited edition prints of Sean Baker‘s Academy Award-nominated screenplay of Anora. The ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares closed last Friday at $137.14.

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...

Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of The Indian Pharmaceutical Combine Association Limited. Ipca is a fully integrated, pharmaceutical company ...

Tesla has launched a limited version of its Full Self-Driving features in China to mixed reviews as it’s still far from what was promised. After many delays, Tesla has now pushed an update that ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from 2025 ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...